Related Experiment Video
Updated: Mar 27, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Role of Ebola Virus vp24 Protein in Inhibition of Interferonogenesis
A A Shelemba1, E L Lushnikova2, S I Kolesnikov3
1Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia. pathol@inbox.eu.
Abstract:
The effects of recombinant analog of natural Ebola virus protein vp24 in configurations virulent (vp24-ad) and avirulent (vp24-w) for guinea pigs on interferonogenesis were studied in vivo and in vitro. Amino acid differences were determined by His186 substitution in avirulent (nonlethal) configuration for Tyr in the virulent (lethal) one. Recombinant analogs vp24-w and vp24-ad inhibited interferonogenesis in vivo and in vitro. Inhibition by the two protein configurations was virtually the same.
Insights
Recombinant Ebola virus protein vp24 analogs, both virulent and avirulent, equally inhibited interferonogenesis in guinea pigs. This suggests vp24
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Ebola virus protein 24 (VP24) is a key virulence factor.
- VP24 interferes with the host immune response, specifically interferon production.
- Understanding VP24's role in interferonogenesis is crucial for developing antiviral strategies.
Purpose of the Study:
- To investigate the effects of recombinant Ebola virus protein VP24 analogs on interferonogenesis.
- To compare the interferonogenesis inhibitory activity of virulent (VP24-ad) and avirulent (VP24-w) VP24 configurations.
- To identify the impact of specific amino acid differences on VP24's function.
Main Methods:
- In vivo and in vitro studies were conducted using guinea pig models.
- Recombinant analogs of Ebola virus protein VP24 (VP24-ad and VP24-w) were synthesized.
- Interferonogenesis was measured to assess the impact of VP24 analogs.
Main Results:
- Both virulent (VP24-ad) and avirulent (VP24-w) recombinant VP24 analogs inhibited interferonogenesis.
- The inhibitory effects of VP24-ad and VP24-w on interferonogenesis were virtually identical.
- A key amino acid difference (His186 in VP24-w vs. Tyr in VP24-ad) was identified between the configurations.
Conclusions:
- Recombinant Ebola virus protein VP24, regardless of its virulent or avirulent configuration, significantly inhibits interferonogenesis.
- The specific amino acid substitution at position 186 does not appear to alter the interferonogenesis inhibitory capacity of VP24.
- These findings highlight VP24's potent role in immune evasion and suggest conserved inhibitory mechanisms across different configurations.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Leaky Scanning
Viruses with RNA Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

